About
Develops AI-driven RNA-based control systems to precisely control and improve the safety of gene and cell therapies through a synthetic biology platform compatible with multiple therapies and technologies.
Explore Concinnity Genetics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.